Clinical trial: Repurposed drug improves outcomes for patients with severe COVID-19 pneumonia
              byUniversity College LondonPrespecified Primary and Secondary endpoints. Credit:eLife(2023). DOI: 10.7554/eLife.87030.1A drug commonly used to treat cystic fibrosis improved outcomes          
          
              
              Updated on: July 17,2024
              
              
                  
                  0              
              
              
          
      Clinical trial: Repurposed drug improves outcomes for patients with severe COVID-19 pneumonia
              byUniversity College LondonPrespecified Primary and Secondary endpoints. Credit:eLife(2023). DOI: 10.7554/eLife.87030.1A drug commonly used to treat cystic fibrosis improved outcomes          
          
              
              Updated on:July 17,2024
              
              
                  
                  0              
              
              
          
      
					
      